The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancer

Aljohani, AI; Toss, MS; Kurozumi, S; Joseph, C; Aleskandarany, MA; Miligy, IM; El Ansari, R; Mongan, NP; Ellis, IO; Green, AR; Rakha, EA

Rakha, EA (corresponding author), Univ Nottingham, Sch Med, Nottingham Breast Canc Res Ctr, Div Canc & Stem Cells, Nottingham, England.; Rakha, EA (corresponding author), Menoufia Univ, Fac Med, Histopathol Dept, Shibin Al Kawm, Egypt.; Rakha, EA (corresponding author), Nottingham Univ Hosp NHS Trust, Dept Histopathol, City Hosp Campus,Hucknall Rd, Nottingham NG5 1PB, England.

BREAST CANCER RESEARCH AND TREATMENT, 2020; 179 (1): 79

Abstract

Background Lymphovascular invasion (LVI) is a prerequisite step in breast cancer (BC) metastasis. We have previously identified wild-type isocitrate d......

Full Text Link